Medical News

RSS

Customer Care department of Murad named finalist for 2010 Stevie Awards

Murad, Inc. announced today that its Customer Care department has been named a finalist for the 2010 Stevie Awards for Customer Service Department of the Year. Thanks to high scores received from the judges after a month-long preliminary judging process, Murad is now one of nine finalists selected from a pool of more than 500 nominees.

12 Feb 2010

Mediterranean diet beneficial to heart health: Study

In countries bordering the Mediterranean Sea, heart disease is less common than in the United States. Researchers believe that foods common to Greece and southern Italy are a major reason for this difference.

12 Feb 2010

Social Security Administration adds early-onset Alzheimer's disease to Compassionate Allowances list: AFA lauds

The Alzheimer's Foundation of America (AFA) today applauded the Social Security Administration for including early-onset Alzheimer's disease among the medical conditions that will be given automatic approval for disability benefits, rather than have individuals go through what could be a lengthy qualification process.

12 Feb 2010

Study analyzes physicians and Medicare insurance claims to investigate volume-offset behavior

Do physicians provide more services to Medicare patients to make up for lower Medicare fees? With almost 42 million people enrolled in Medicare in the United States in 2008, it's a question that could have a very costly answer.

12 Feb 2010

SEC declares CCBC's registration statement effective

China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Securities and Exchange Commission ("SEC") declared the Company's registration statement effective on February 9, 2010. The registration statement relates to the ordinary shares underlying warrants and certain other securities issued in connection with the initial public offering of Pantheon China Acquisition Corp.

12 Feb 2010

IBM, VLSCI scientists to use Blue Gene supercomputer to study human disease

IBM today announced a Research collaboratory in Melbourne, Australia, where scientists from the Victorian Life Sciences Computational Initiative at the University of Melbourne and the IBM Research Computational Biology Center will use high performance computing – including IBM's Blue Gene supercomputer – to study human disease.

12 Feb 2010

Kaiser Permanente approves 500 grants and donations totaling $90M in fourth-quarter of 2009

Kaiser Permanente, one of America's leading health care providers and nonprofit health plans, announced today it approved 500 grants and donations nationwide totaling $90 million in the fourth quarter of 2009. In total, Kaiser Permanente approved $170 million in grants and donations to support efforts to keep people healthy during these tough economic times.

12 Feb 2010

KHN column -- Don't stop now: Lawmakers should pass the Senate bill

In her latest column for Kaiser Health News, Judy Feder writes: "Veterans of health reform battles know all too well that enacting health reform is as challenging to the nation's political system as it is important to the nation's well-being.

12 Feb 2010

Study: Hospitalizations for H1N1 differ from hospitalizations associated with typical flu

When compared to a typical flu, the H1N1 virus resulted in a higher proportion of patients requiring specialized hospital services - and affected younger people more - according to a new study released today by the Canadian Institute for Health Information (CIHI).

12 Feb 2010

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

12 Feb 2010

Regence introduces Evolve to meet full spectrum of consumers' healthcare needs

Regence introduces Evolve, a new portfolio of individual health plans designed to meet the full spectrum of consumers' needs. From children needing preventative care, unemployed individuals seeking core coverage or a family searching for comprehensive benefits, Evolve has options to meet each unique situation.

12 Feb 2010

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, says Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women's HealthSource.

12 Feb 2010

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise metabolism, and/or scientific policies related to sports nutrition.

12 Feb 2010

Heavy rains hit tent camps in Haiti

Heavy rains hit earthquake survivors in tent camps in Port-au-Prince on Thursday, "bringing a warning of fresh misery to come for the 1 million people living on the streets," Reuters reports.

12 Feb 2010

OrbusNeich commences enrollment in Chinese Genous Bio-engineered R stent trial

OrbusNeich today announced that the first patient has been enrolled in a randomized clinical trial of the Genous Bio-engineered R stent in China.

12 Feb 2010

CapitalBio officially joins Roche NimbleGen CSP Program

Roche NimbleGen announced today that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

12 Feb 2010

ASU scientists develop versatile DNA reader to unlock DNA genetic code

Arizona State University scientists have come up with a new twist in their efforts to develop a faster and cheaper way to read the DNA genetic code. They have developed the first, versatile DNA reader that can discriminate between DNA's four core chemical components⎯the key to unlocking the vital code behind human heredity and health.

12 Feb 2010

Proving value a challenge for comparative effectiveness and pharmaceutical technologies

The Wall Street Journal reports that "an examination of one of the best-known examples of a comparative-effectiveness analysis shows how complicated such a seemingly straightforward idea can get" as officials look for savings in the health care system." One study, called Courage, "found that the most common heart surgery -- a $15,000 procedure that unclogs arteries using a small scaffold or stent -- usually yields no additional benefit when used with a cocktail of generic drugs in patients suffering from chronic chest pain."

12 Feb 2010

AMC receives GWTG-Stroke Gold Performance Achievement Award for caring stroke patients

Adventist Medical Center recently received the American Heart Association/American Stroke Association's Get With The Guidelines (GWTG) - Stroke Gold Performance Achievement Award. The award recognizes AMC's commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations provided by the AHA/ASA.

12 Feb 2010

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

Biologics, Inc., the leading cancer management company in the United States, announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program® (NMDP), a nonprofit organization that facilitates unrelated hematopoietic cell transplants.

12 Feb 2010

Medical News

Customer Care department of Murad named finalist for 2010 Stevie Awards

Mediterranean diet beneficial to heart health: Study

Social Security Administration adds early-onset Alzheimer's disease to Compassionate Allowances list: AFA lauds

Study analyzes physicians and Medicare insurance claims to investigate volume-offset behavior

SEC declares CCBC's registration statement effective

IBM, VLSCI scientists to use Blue Gene supercomputer to study human disease

Kaiser Permanente approves 500 grants and donations totaling $90M in fourth-quarter of 2009

KHN column -- Don't stop now: Lawmakers should pass the Senate bill

Study: Hospitalizations for H1N1 differ from hospitalizations associated with typical flu

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Regence introduces Evolve to meet full spectrum of consumers' healthcare needs

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

Heavy rains hit tent camps in Haiti

OrbusNeich commences enrollment in Chinese Genous Bio-engineered R stent trial

CapitalBio officially joins Roche NimbleGen CSP Program

ASU scientists develop versatile DNA reader to unlock DNA genetic code

Proving value a challenge for comparative effectiveness and pharmaceutical technologies

AMC receives GWTG-Stroke Gold Performance Achievement Award for caring stroke patients

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News